Impedance Cardiology Systems Inc., a Menlo Park, Calif.-based biotech startup, has raised $5 million in Series B funding, according to a regulatory filing cited by PE Week. Backers include Versant Ventures and Starfish Ventures (Australia).

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.